MLchartDataset catalogue

autologous ovarian cancer immunogene-modified T lymphocytes

Term · Oncology and biomedicine · MLC-T-ONC-011730

A preparation of autologous immunogene modified T lymphocytes (IgT) that have been genetically engineered to be specifically reactive to ovarian cancer (OC) cells, with potential antineoplastic and immunostimulating activities. Upon administration of the autologous OC-IgT cells, the T cells recognize and induce specific toxicity in the OC cells.

Table 1. Record
IdentifierMLC-T-ONC-011730
FieldOncology and biomedicine
SynonymsOC-IgT cells; autologous human OC-IgT cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011730",
  "term": "autologous ovarian cancer immunogene-modified T lymphocytes",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous immunogene modified T lymphocytes (IgT) that have been genetically engineered to be specifically reactive to ovarian cancer (OC) cells, with potential antineoplastic and immunostimulating activities. Upon administration of the autologous OC-IgT cells, the T cells recognize and induce specific toxicity in the OC cells.",
  "synonyms": [
    "OC-IgT cells",
    "autologous human OC-IgT cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-ovarian-cancer-immunogene-modified-t-lymphocytes/"
}

Record 3,066 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.